INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 203 filers reported holding INSMED INC in Q1 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $82 | +20.6% | 3,263 | 0.0% | 0.00% | – |
| Q2 2023 | $68 | -84.6% | 3,263 | -87.4% | 0.00% | -100.0% |
| Q1 2023 | $442 | +927.9% | 25,958 | +1102.9% | 0.00% | – |
| Q4 2022 | $43 | -100.0% | 2,158 | -80.1% | 0.00% | – |
| Q3 2022 | $233,000 | -8.6% | 10,848 | -16.3% | 0.00% | – |
| Q2 2022 | $255,000 | -52.3% | 12,968 | -43.1% | 0.00% | -100.0% |
| Q1 2022 | $535,000 | -34.9% | 22,785 | -24.5% | 0.00% | 0.0% |
| Q4 2021 | $822,000 | -39.5% | 30,189 | -38.8% | 0.00% | -50.0% |
| Q3 2021 | $1,358,000 | +1686.8% | 49,345 | +2036.1% | 0.00% | – |
| Q4 2020 | $76,000 | +10.1% | 2,310 | +6.4% | 0.00% | – |
| Q3 2020 | $69,000 | +40.8% | 2,171 | -30.4% | 0.00% | – |
| Q1 2020 | $49,000 | +1125.0% | 3,119 | +1034.2% | 0.00% | – |
| Q3 2013 | $4,000 | – | 275 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,799,225 | $40,519,000 | 16.80% |
| Foresite Capital Management II, LLC | 967,636 | $21,791,000 | 7.25% |
| Palo Alto Investors LP | 7,159,590 | $161,234,000 | 6.90% |
| Asymmetry Capital Management, L.P. | 162,185 | $3,652,000 | 4.57% |
| NEXTHERA CAPITAL LP | 918,523 | $20,685,000 | 3.41% |
| Redmile Group, LLC | 2,166,362 | $48,786,000 | 1.88% |
| Orbimed Advisors | 2,927,891 | $65,936,000 | 0.82% |
| Rock Springs Capital Management LP | 825,000 | $18,579,000 | 0.79% |
| Bellevue Group AG | 334,489 | $7,533,000 | 0.75% |
| EMERALD ADVISERS, LLC | 726,946 | $16,371,000 | 0.66% |